Clinical Trial: Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07007078) titled 'Efficacy of Dihydroartemisinin for Treating Acne Vulgaris' on May 28.

Brief Summary: The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is:

* Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris.

Participants will:

* Take DHA every day for 3 months

* Visit the clinic once every month for checkups and tests

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: ...